Titre : Manifestations neuromusculaires

Manifestations neuromusculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Colorectal Neoplasms

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une myopathie ?

Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire.
Myopathies Biopsie musculaire
#2

Quels examens pour les neuropathies ?

Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse.
Neuropathies Électromyographie
#3

Quel rôle des tests génétiques ?

Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques.
Tests génétiques Maladies héréditaires
#4

Comment évaluer la force musculaire ?

La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées.
Force musculaire Évaluation clinique
#5

Quand faire une IRM musculaire ?

L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles.
Imagerie par résonance magnétique Anomalies musculaires

Symptômes 5

#1

Quels sont les symptômes d'une dystrophie musculaire ?

Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher.
Dystrophies musculaires Faiblesse musculaire
#2

Comment se manifeste une neuropathie périphérique ?

Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres.
Neuropathies périphériques Douleur neuropathique
#3

Quels signes d'une myasthénie ?

Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition.
Myasthénie Fatigue musculaire
#4

Quels symptômes d'une sclérose latérale amyotrophique ?

Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler.
Sclérose latérale amyotrophique Difficultés de déglutition
#5

Comment reconnaître un syndrome de Guillain-Barré ?

Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués.
Syndrome de Guillain-Barré Faiblesse musculaire

Prévention 5

#1

Peut-on prévenir les neuropathies ?

La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines.
Neuropathies Prévention des maladies
#2

Comment prévenir les crampes musculaires ?

L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes.
Crampes musculaires Hydratation
#3

Y a-t-il des mesures préventives pour la myopathie ?

Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes.
Myopathies Diagnostic précoce
#4

Comment éviter les blessures musculaires ?

Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures.
Blessures musculaires Échauffement
#5

Peut-on prévenir la sclérose latérale amyotrophique ?

Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique.
Sclérose latérale amyotrophique Prévention

Traitements 5

#1

Quels traitements pour la myopathie ?

Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs.
Myopathies Corticostéroïdes
#2

Comment traiter une neuropathie diabétique ?

Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques.
Neuropathies diabétiques Contrôle glycémique
#3

Quel est le traitement de la myasthénie ?

Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs.
Myasthénie Inhibiteurs de l'acétylcholinestérase
#4

Quelles options pour la sclérose latérale amyotrophique ?

Les options incluent des médicaments pour ralentir la progression et des soins palliatifs.
Sclérose latérale amyotrophique Soins palliatifs
#5

Comment gérer le syndrome de Guillain-Barré ?

Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique.
Syndrome de Guillain-Barré Immunoglobulines

Complications 5

#1

Quelles complications des myopathies ?

Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques.
Myopathies Complications respiratoires
#2

Quels risques avec la neuropathie ?

Les risques incluent des blessures dues à une perte de sensation et des infections cutanées.
Neuropathies Infections cutanées
#3

Quelles complications de la myasthénie ?

Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition.
Myasthénie Crises myasthéniques
#4

Quels problèmes liés à la sclérose latérale amyotrophique ?

Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections.
Sclérose latérale amyotrophique Paralysie
#5

Quelles complications du syndrome de Guillain-Barré ?

Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques.
Syndrome de Guillain-Barré Complications neurologiques

Facteurs de risque 5

#1

Quels facteurs de risque pour les myopathies ?

Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques.
Myopathies Antécédents familiaux
#2

Quels risques pour la neuropathie diabétique ?

Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie.
Neuropathies diabétiques Diabète
#3

Quels facteurs de risque pour la myasthénie ?

Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux.
Myasthénie Maladies auto-immunes
#4

Quels risques pour la sclérose latérale amyotrophique ?

Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux.
Sclérose latérale amyotrophique Âge avancé
#5

Quels facteurs de risque pour le syndrome de Guillain-Barré ?

Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque.
Syndrome de Guillain-Barré Infections virales
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Manifestations neuromusculaires : Questions médicales les plus fréquentes", "headline": "Manifestations neuromusculaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Manifestations neuromusculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-13", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Manifestations neuromusculaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Manifestations neurologiques", "url": "https://questionsmedicales.fr/mesh/D009461", "about": { "@type": "MedicalCondition", "name": "Manifestations neurologiques", "code": { "@type": "MedicalCode", "code": "D009461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Fasciculation", "alternateName": "Fasciculation", "url": "https://questionsmedicales.fr/mesh/D005207", "about": { "@type": "MedicalCondition", "name": "Fasciculation", "code": { "@type": "MedicalCode", "code": "D005207", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.250" } } }, { "@type": "MedicalWebPage", "name": "Crampe musculaire", "alternateName": "Muscle Cramp", "url": "https://questionsmedicales.fr/mesh/D009120", "about": { "@type": "MedicalCondition", "name": "Crampe musculaire", "code": { "@type": "MedicalCode", "code": "D009120", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.500" } } }, { "@type": "MedicalWebPage", "name": "Hypertonie musculaire", "alternateName": "Muscle Hypertonia", "url": "https://questionsmedicales.fr/mesh/D009122", "about": { "@type": "MedicalCondition", "name": "Hypertonie musculaire", "code": { "@type": "MedicalCode", "code": "D009122", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Raideur musculaire", "alternateName": "Muscle Rigidity", "url": "https://questionsmedicales.fr/mesh/D009127", "about": { "@type": "MedicalCondition", "name": "Raideur musculaire", "code": { "@type": "MedicalCode", "code": "D009127", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550.500" } } }, { "@type": "MedicalWebPage", "name": "Spasticité musculaire", "alternateName": "Muscle Spasticity", "url": "https://questionsmedicales.fr/mesh/D009128", "about": { "@type": "MedicalCondition", "name": "Spasticité musculaire", "code": { "@type": "MedicalCode", "code": "D009128", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.550.550" } } } ] }, { "@type": "MedicalWebPage", "name": "Hypotonie musculaire", "alternateName": "Muscle Hypotonia", "url": "https://questionsmedicales.fr/mesh/D009123", "about": { "@type": "MedicalCondition", "name": "Hypotonie musculaire", "code": { "@type": "MedicalCode", "code": "D009123", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.575" } } }, { "@type": "MedicalWebPage", "name": "Faiblesse musculaire", "alternateName": "Muscle Weakness", "url": "https://questionsmedicales.fr/mesh/D018908", "about": { "@type": "MedicalCondition", "name": "Faiblesse musculaire", "code": { "@type": "MedicalCode", "code": "D018908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.593" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de la tête tombante", "alternateName": "Dropped Head Syndrome", "url": "https://questionsmedicales.fr/mesh/D000094222", "about": { "@type": "MedicalCondition", "name": "Syndrome de la tête tombante", "code": { "@type": "MedicalCode", "code": "D000094222", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.593.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Amyotrophie", "alternateName": "Muscular Atrophy", "url": "https://questionsmedicales.fr/mesh/D009133", "about": { "@type": "MedicalCondition", "name": "Amyotrophie", "code": { "@type": "MedicalCode", "code": "D009133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.612" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sarcopénie", "alternateName": "Sarcopenia", "url": "https://questionsmedicales.fr/mesh/D055948", "about": { "@type": "MedicalCondition", "name": "Sarcopénie", "code": { "@type": "MedicalCode", "code": "D055948", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.612.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Myokymie", "alternateName": "Myokymia", "url": "https://questionsmedicales.fr/mesh/D020385", "about": { "@type": "MedicalCondition", "name": "Myokymie", "code": { "@type": "MedicalCode", "code": "D020385", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.650" } } }, { "@type": "MedicalWebPage", "name": "Myotonie", "alternateName": "Myotonia", "url": "https://questionsmedicales.fr/mesh/D009222", "about": { "@type": "MedicalCondition", "name": "Myotonie", "code": { "@type": "MedicalCode", "code": "D009222", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.700" } } }, { "@type": "MedicalWebPage", "name": "Spasme", "alternateName": "Spasm", "url": "https://questionsmedicales.fr/mesh/D013035", "about": { "@type": "MedicalCondition", "name": "Spasme", "code": { "@type": "MedicalCode", "code": "D013035", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Spasme hémifacial", "alternateName": "Hemifacial Spasm", "url": "https://questionsmedicales.fr/mesh/D019569", "about": { "@type": "MedicalCondition", "name": "Spasme hémifacial", "code": { "@type": "MedicalCode", "code": "D019569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750.400" } } }, { "@type": "MedicalWebPage", "name": "Trismus", "alternateName": "Trismus", "url": "https://questionsmedicales.fr/mesh/D014313", "about": { "@type": "MedicalCondition", "name": "Trismus", "code": { "@type": "MedicalCode", "code": "D014313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.750.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Tétanie", "alternateName": "Tetany", "url": "https://questionsmedicales.fr/mesh/D013746", "about": { "@type": "MedicalCondition", "name": "Tétanie", "code": { "@type": "MedicalCode", "code": "D013746", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.608.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Manifestations neuromusculaires", "alternateName": "Neuromuscular Manifestations", "code": { "@type": "MedicalCode", "code": "D020879", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael S Cartwright", "url": "https://questionsmedicales.fr/author/Michael%20S%20Cartwright", "affiliation": { "@type": "Organization", "name": "Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA." } }, { "@type": "Person", "name": "Heinz Jungbluth", "url": "https://questionsmedicales.fr/author/Heinz%20Jungbluth", "affiliation": { "@type": "Organization", "name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk." } }, { "@type": "Person", "name": "David Lacomis", "url": "https://questionsmedicales.fr/author/David%20Lacomis", "affiliation": { "@type": "Organization", "name": "Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States." } }, { "@type": "Person", "name": "Miguel A Fernandez-Garcia", "url": "https://questionsmedicales.fr/author/Miguel%20A%20Fernandez-Garcia", "affiliation": { "@type": "Organization", "name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom." } }, { "@type": "Person", "name": "Ruple S Laughlin", "url": "https://questionsmedicales.fr/author/Ruple%20S%20Laughlin", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Acromegaly and Colorectal Neoplasm: An Update.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35795151", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2022.924952" } }, { "@type": "ScholarlyArticle", "name": "Artificial intelligence for the prevention and prediction of colorectal neoplasms.", "datePublished": "2023-07-03", "url": "https://questionsmedicales.fr/article/37400891", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12967-023-04258-5" } }, { "@type": "ScholarlyArticle", "name": "The comparison of risk factors for colorectal neoplasms at different anatomical sites.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/36719544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00384-022-04296-3" } }, { "@type": "ScholarlyArticle", "name": "Gastroenterologist and surgeon perceptions of recommendations for optimal endoscopic localization of colorectal neoplasms.", "datePublished": "2024-06-07", "url": "https://questionsmedicales.fr/article/38849393", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-63753-x" } }, { "@type": "ScholarlyArticle", "name": "Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36769274", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24032952" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Manifestations neuromusculaires", "item": "https://questionsmedicales.fr/mesh/D020879" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Manifestations neuromusculaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Manifestations neuromusculaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Manifestations neuromusculaires", "description": "Comment diagnostiquer une myopathie ?\nQuels examens pour les neuropathies ?\nQuel rôle des tests génétiques ?\nComment évaluer la force musculaire ?\nQuand faire une IRM musculaire ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Manifestations neuromusculaires", "description": "Quels sont les symptômes d'une dystrophie musculaire ?\nComment se manifeste une neuropathie périphérique ?\nQuels signes d'une myasthénie ?\nQuels symptômes d'une sclérose latérale amyotrophique ?\nComment reconnaître un syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Manifestations neuromusculaires", "description": "Peut-on prévenir les neuropathies ?\nComment prévenir les crampes musculaires ?\nY a-t-il des mesures préventives pour la myopathie ?\nComment éviter les blessures musculaires ?\nPeut-on prévenir la sclérose latérale amyotrophique ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Manifestations neuromusculaires", "description": "Quels traitements pour la myopathie ?\nComment traiter une neuropathie diabétique ?\nQuel est le traitement de la myasthénie ?\nQuelles options pour la sclérose latérale amyotrophique ?\nComment gérer le syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Manifestations neuromusculaires", "description": "Quelles complications des myopathies ?\nQuels risques avec la neuropathie ?\nQuelles complications de la myasthénie ?\nQuels problèmes liés à la sclérose latérale amyotrophique ?\nQuelles complications du syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Manifestations neuromusculaires", "description": "Quels facteurs de risque pour les myopathies ?\nQuels risques pour la neuropathie diabétique ?\nQuels facteurs de risque pour la myasthénie ?\nQuels risques pour la sclérose latérale amyotrophique ?\nQuels facteurs de risque pour le syndrome de Guillain-Barré ?", "url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Colorectal+Neoplasms#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une myopathie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire." } }, { "@type": "Question", "name": "Quels examens pour les neuropathies ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse." } }, { "@type": "Question", "name": "Quel rôle des tests génétiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques." } }, { "@type": "Question", "name": "Comment évaluer la force musculaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées." } }, { "@type": "Question", "name": "Quand faire une IRM musculaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dystrophie musculaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher." } }, { "@type": "Question", "name": "Comment se manifeste une neuropathie périphérique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres." } }, { "@type": "Question", "name": "Quels signes d'une myasthénie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition." } }, { "@type": "Question", "name": "Quels symptômes d'une sclérose latérale amyotrophique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler." } }, { "@type": "Question", "name": "Comment reconnaître un syndrome de Guillain-Barré ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués." } }, { "@type": "Question", "name": "Peut-on prévenir les neuropathies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines." } }, { "@type": "Question", "name": "Comment prévenir les crampes musculaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives pour la myopathie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes." } }, { "@type": "Question", "name": "Comment éviter les blessures musculaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures." } }, { "@type": "Question", "name": "Peut-on prévenir la sclérose latérale amyotrophique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique." } }, { "@type": "Question", "name": "Quels traitements pour la myopathie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Comment traiter une neuropathie diabétique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques." } }, { "@type": "Question", "name": "Quel est le traitement de la myasthénie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs." } }, { "@type": "Question", "name": "Quelles options pour la sclérose latérale amyotrophique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent des médicaments pour ralentir la progression et des soins palliatifs." } }, { "@type": "Question", "name": "Comment gérer le syndrome de Guillain-Barré ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique." } }, { "@type": "Question", "name": "Quelles complications des myopathies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques." } }, { "@type": "Question", "name": "Quels risques avec la neuropathie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des blessures dues à une perte de sensation et des infections cutanées." } }, { "@type": "Question", "name": "Quelles complications de la myasthénie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition." } }, { "@type": "Question", "name": "Quels problèmes liés à la sclérose latérale amyotrophique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections." } }, { "@type": "Question", "name": "Quelles complications du syndrome de Guillain-Barré ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les myopathies ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques." } }, { "@type": "Question", "name": "Quels risques pour la neuropathie diabétique ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la myasthénie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels risques pour la sclérose latérale amyotrophique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le syndrome de Guillain-Barré ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 07/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Michael S Cartwright

4 publications dans cette catégorie

Affiliations :
  • Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Manifestations neuromusculaires" :

Heinz Jungbluth

3 publications dans cette catégorie

Affiliations :
  • Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk.
Publications dans "Manifestations neuromusculaires" :

David Lacomis

3 publications dans cette catégorie

Affiliations :
  • Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
  • Department of Pathology (Neuropathology), University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Publications dans "Manifestations neuromusculaires" :

Miguel A Fernandez-Garcia

2 publications dans cette catégorie

Affiliations :
  • Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
Publications dans "Manifestations neuromusculaires" :

Ruple S Laughlin

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Publications dans "Manifestations neuromusculaires" :

Anthony A Amato

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Division of Neuromuscular Diseases, Neuropathology Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Publications dans "Manifestations neuromusculaires" :

Luuk R van den Bersselaar

2 publications dans cette catégorie

Affiliations :
  • Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
  • Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :

Sheila Riazi

2 publications dans cette catégorie

Affiliations :
  • Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Manifestations neuromusculaires" :

Nicol C Voermans

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :

Marc M J Snoeck

2 publications dans cette catégorie

Affiliations :
  • Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :

Karissa L Gable

2 publications dans cette catégorie

Publications dans "Manifestations neuromusculaires" :

Nens van Alfen

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :

Nicola A Maffiuletti

2 publications dans cette catégorie

Affiliations :
  • Human Performance Laboratory, Schulthess Clinic, Zurich, Switzerland.

Bengt Kayser

2 publications dans cette catégorie

Affiliations :
  • Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Nicolas Place

2 publications dans cette catégorie

Affiliations :
  • Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Sarada Sakamuri

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
Publications dans "Manifestations neuromusculaires" :

Amanda C Guidon

2 publications dans cette catégorie

Affiliations :
  • Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Manifestations neuromusculaires" :

Rajesh Benny

1 publication dans cette catégorie

Affiliations :
  • Senior Consultant and Associate Professor of Neurology, Fortis Hospital, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :

Satish V Khadilkar

1 publication dans cette catégorie

Affiliations :
  • Dean, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :

Christyn Edmundson

1 publication dans cette catégorie

Affiliations :
  • Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Manifestations neuromusculaires" :

Sources (10000 au total)

Artificial intelligence for the prevention and prediction of colorectal neoplasms.

Colonoscopy is a useful as a cancer screening test. However, in countries with limited medical resources, there are restrictions on the widespread use of endoscopy. Non-invasive screening methods to d... We used data from physical exams and blood analyses to determine the incidence of colorectal polyp. However, these features exhibit highly overlapping classes. The use of a kernel density estimator (K... Along with an adequate polyp size threshold, the optimal machine learning (ML) models' performance provided 0.37 and 0.39 Matthews correlation coefficient (MCC) for the datasets of men and women, resp... The ML model can be chosen according to the desired polyp size discrimination threshold, may suggest further colorectal screening, and possible adenoma size. The KDE feature transformation could serve...

The comparison of risk factors for colorectal neoplasms at different anatomical sites.

Both the clinical manifestation and molecular characteristics of colorectal cancer (CRC) vary according to the anatomical site. We explored the risk factors for four groups of colorectal neoplasms (CR... We extracted data from the database of Tianjin Colorectal Cancer Screening Program from 2010 to 2020. According to the CRN anatomical sites, patients were divided into four groups: the proximal colon ... The numbers of patients with CRN in the proximal colon, distal colon, rectum, and multiple colorectal sites were 4023, 6920, 3657, and 7938, respectively. Male sex was associated with a higher risk fr... We observed differences in advanced age, obesity, smoking, alcohol consumption, and family history of colorectal cancer at different anatomical sites of colorectal neoplasms. These factors vary by gen...

Recommendations for Optimal Endoscopic Localization of Colorectal Neoplasms: A Delphi Consensus of National Experts.

Colonoscopy is the standard of care for diagnosis and evaluation of colorectal cancers before surgery. However, varied practices and heterogenous documentation affects communication between endoscopis... This study aimed to develop recommendations for the use of standardized localization and reporting practices for colorectal lesions identified during lower GI endoscopy.... A systematic review of existing endoscopy guidelines and thorough narrative review of the overall endoscopy literature were performed to identify existing practices recommended globally.... An online Delphi process was used to establish consensus recommendations based on a literature review.... Colorectal surgeons and gastroenterologists from across Canada who had previously demonstrated leadership in endoscopy, managed large endoscopy programs, produced high-impact publications in the field... The primary outcomes measured were colorectal lesion localization and documentation practice recommendations important to planning surgical or advanced endoscopic excisions.... A total of 129 of 197 statements achieved consensus after 3 rounds of voting by 23 experts from across Canada. There was more than 90% participation in each round. Recommendations varied according to ... Because of a paucity of evidence, recommendations are based primarily on expert opinion. There may be bias, as all representatives were based in Canada.... Best practices to optimize endoscopic lesion localization and communication are not addressed in previous guidelines. This consensus involving national experts in colorectal surgery and gastroenterolo... ANTECEDENTES:La colonoscopia es el estándar de atención para el diagnóstico y la evaluación de los cánceres colorrectales antes de la cirugía. Sin embargo, las prácticas variadas y la documentación he...

Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.

The Asia-Pacific Colorectal Screening (APCS) scoring system was developed to stratify the risk of colorectal advanced neoplasm (AN). We aimed to evaluate the performance of the APCS score combined wit... A total of 2842 subjects who visited outpatient clinics or cancer screening centers were enrolled. Age, sex, smoking status, and family history were recorded and APCS scores were calculated in 2439 pa... Based on the APCS score, 38.8% (946 of 2439) of the subjects were categorized as high risk, and they had a 1.8-fold increase in risk for AN (95% CI, 1.4-2.3) compared with low and moderate risk. The A... The APCS score combined with a stool DNA test significantly improved the detection of colorectal ANs, while limiting colonoscopy resource utilization (Chictr.org.cn, ChiCTR-DDD-17011169)....

Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history.

Screening recommendations for colorectal cancer (CRC) are mainly based on family history rather than lifestyle risk factors. We aimed to assess and compare risk factors for colorectal neoplasm (CRN) a... This study was based on 89,535 first-recorded colonoscopies in Tianjin CRC screening program, 2012-2020. Of these, 45,380 individuals with complete family history and lifestyle factors were included f... The overall detection rate of nonadvanced adenomas, advanced adenomas and CRC was 39.3%, 5.9% and 1.5%, respectively. The PAFs of current smoking, alcohol consumption, physical activity, higher BMI an... Modifiable lifestyle factors, including smoking, alcohol consumption, physical activity and BMI, have a larger contribution to CRN than family history of CRC. Our findings will provide references for ...

Optimal endoscopic localization of colorectal neoplasms: a comparison of rural versus urban documentation practices.

Colonoscopy is the gold standard for diagnosing colorectal neoplasms. However, colonoscopy is often repeated preoperatively due to non-standard documentation and inconsistent practices by index endosc... We performed a retrospective review of patients who underwent elective surgery for colorectal neoplasms at a single institution in Winnipeg between 2007-2020. We compared endoscopy report quality to t... One hundred ninety-four patients were included (97 rural, 97 urban). The mean overall compliance with the recommendations for urban endoscopies was marginally better compared to rural endoscopies (50%... Endoscopists frequently omit recommended practices for optimal colorectal lesion localization. Rural reports miss more recommended information compared to urban reports. Future research is needed to f...